This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Zymeworks Bc Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sukhbir Singh Kang: Innovator in Antibody-Drug Conjugates
Introduction
Sukhbir Singh Kang is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapeutics through his innovative work on antibody-drug conjugates.
Latest Patents
Kang holds a patent for "Antibody-drug conjugates targeting folate receptor alpha and methods of use." This patent describes antibody-drug conjugates (ADCs) that comprise an antibody construct specifically designed to bind to the human folate receptor alpha (FRα). The ADCs are particularly useful in the treatment of cancer, utilizing a camptothecin analogue for therapeutic purposes.
Career Highlights
Sukhbir Singh Kang is associated with Zymeworks BC Inc., where he continues to advance his research and development in the field of biopharmaceuticals. His work focuses on creating innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Kang collaborates with esteemed colleagues, including James R. Rich and Stuart Daniel Barnscher, to further enhance the impact of his research and innovations.
Conclusion
Sukhbir Singh Kang's contributions to the field of antibody-drug conjugates exemplify his dedication to advancing cancer therapeutics. His innovative work continues to pave the way for new treatment options, making a significant impact in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile